Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Lakefront Biotherapeutics NV (LKFT34.SA) Q2 2026 Earnings
LKFT34.SA
6
May
Confirmed
Q2 2026
-4.65
-2.7
-0.75
1.2
Details
Expected EPS
-4.649700424309984
Actual EPS
1.19799853152
Surprise EPS
5.85
Surprise Percent
+125.77%
Description
Lakefront Biotherapeutics NV (LKFT34.SA) has reported earnings of 1.19799853152 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login